...
The three FDA-approved drugs are Marinol, Cesamet, and Syndros. Drugs like Syndros show great promise for countering today’s dangerous “medical marijuana” movement.
In early July, the FDA approved Syndros as the first orally administered liquid form of THC. Like Marinol, the original oral cannabinoid to gain FDA approval in 1985, Syndros treats anorexia associated with weight loss in patients with AIDS, as well as nausea and vomiting caused by cancer chemotherapy.
Epidiolex is one drug currently on the FDA fast track. According to a recent press release from GW Pharmaceuticals, a study of 171 randomized patients suffering from Lennox-Gastaut and Dravet syndromes found that Epidiolex decreased seizure occurrence, was relatively well tolerated among patients, and generated no unexpected adverse effects.
Other cannabinoid-based medications on the international market today include Cesamet, another synthetic drug that treats nausea and vomiting stemming from chemotherapy; Cannador, which is currently used in Europe and has demonstrated potential to relieve multiple sclerosis symptoms and postoperative pain management; and Sativex, another GW Pharmaceuticals drug on the FDA fast track that treats spasticity caused by multiple sclerosis.
Since these are all medical cannabinoids, they do not require smoking. They are also safer to use because levels of THC can be monitored.
Knowing these safer alternatives exist, ask yourself: Why? Why have the pot pushers kept this secret and why don’t they want you to know this?
...
Cannabinoid-based drugs are better alternatives because they reap the benefits of marijuana’s therapeutic components safely, as well as have the potential to become FDA approved if they aren’t already.
So the next time a pot pusher encourages a state to enact so-called “medical marijuana” laws, or goes for full legalization in violation of federal law, ask them: Why are they pushing an unsafe, untested product instead of pushing FDA-approved THC?
http://dailysignal.com/2016/08/04/th...ampaign=thf-fb
Connect With Us